Laura is an experienced Business Development and Strategic Manager with a strong track record in the cell and gene therapy sector. At NHS Blood and Transplant, she leads commercial engagement for GMP manufacturing services across plasmid, viral vector, and cell therapy platforms, supporting projects from early development through to clinical delivery. With a background in neuroscience and previous roles at eXmoor Pharma and Thermo Fisher Scientific, Laura brings deep market insight and a collaborative, client-focused approach. She is a passionate advocate for building long-term academic and commercial partnerships to scale innovation and accelerate patient access to advanced therapies.